Glenmark Pharmaceuticals Recalls Abiraterone Acetate Tablets Due to Labeling Issue
Glenmark Pharmaceuticals Inc. is recalling 1,296 bottles of Abiraterone Acetate Tablets USP 500 mg due to a labeling error.
Glenmark Pharmaceuticals Inc., USA is recalling 1,296 bottles of Abiraterone Acetate Tablets USP 500 mg. The prescription medication is packaged in 60-count bottles.
The recall was issued due to a labeling issue. The U.S. Food and Drug Administration has classified this action as a Class II recall.
The recalled product was distributed nationwide across the United States.
What to do
- Stop taking the recalled medication.
- Contact your healthcare provider or pharmacist before discontinuing or changing your prescription medication.
- Contact Glenmark Pharmaceuticals Inc., USA or the FDA for additional details regarding the recall.
At a glance
| Agency | U.S. Food and Drug Administration (FDA) |
|---|---|
| Recall number | D-0074-2027 |
| Date | 2026-11-04 |
| Company | Glenmark Pharmaceuticals Inc., USA, Elmwood Park, NJ |
| Severity | Class II |
| Quantity | 1296 bottles |
| Where sold | Nationwide within the United States |
| Lot codes / identifiers | Lot #: 13250135, Exp. Date 11/2027 |
Source: official FDA notice. This summary was written by 365 News from the official notice. Details can change; check the notice before acting.